methyl 3-(naphthalen-2-yloxy)benzoate | 1027423-17-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl 3-(naphthalen-2-yloxy)benzoate
• 英文别名: Methyl 3-naphthalen-2-yloxybenzoate
• CAS: 1027423-17-1
• 化学式: C₁₈H₁₄O₃
• 分子量: 278.307
• InChiKey: NTOLUJHNGAWUDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 3-(naphthalen-2-yloxy)benzoate 在 lithium hydroxide 、 草酰氯 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 2.5h， 生成 2-[3-(Naphthalen-2-yloxy)-benzoylamino]-benzoic acid methyl ester
  参考文献：
  名称：

  新型萘衍生物可作为人类免疫球蛋白E抗体产生的抑制剂。

  摘要：

  制备了一系列在2位带有多个取代基的萘衍生物，以评估其对由抗CD40抗体（α-CD40）激发的人外周血单核细胞对免疫球蛋白E（IgE）抗体产生的抑制作用，白介素4（IL-4）和白介素10（IL-10）。在2萘基核和邻氨基苯甲酸之间具有1,4-亚苯基间隔区的化合物优先于IgG抗体在体外抑制IgE抗体的产生，而不会影响细胞生存力。邻氨基苯甲酸部分的缺失减少了抑制活性。将2-萘基变为1-萘基或苯基核不会导致效力改变，表明该位置的芳族基团对于抑制活性是必不可少的。另一方面，更改1 将4-亚苯基间隔基与1，3-亚苯基间隔基导致效力降低。类似地，当2位的CO2H部分移至末端苯的3位或4位时，抑制活性丧失。这些观察结果表明，邻氨基苯甲酸部分周围的构象影响了对IgE生物合成的抑制活性。2-（4-（2-萘氧基）苯甲酰胺基）苯甲酸（29）似乎是IgE产生比IgG产生更有效的抑制剂。亚甲基在亚苯基间和酰胺部分之​

  DOI：

  10.1021/jm9605041
• 作为产物：
  描述：

  3-溴苯甲酸甲酯 、 2-萘酚 在 potassium phosphate 、 palladium diacetate 、 2-二-叔丁膦基-2',4',6'-三异丙基联苯 作用下， 以 甲苯 为溶剂， 反应 16.0h， 以33%的产率得到methyl 3-(naphthalen-2-yloxy)benzoate
  参考文献：
  名称：

  Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach

  摘要：

  Sirtuin 2 (SIRT2) is one of the sirtuins, a family of NAD(+)-dependent deacetylases that act on a variety of histone and non-histone substrates. Accumulating biological functions and potential therapeutic applications have drawn interest in the discovery and development of SIRT2 inhibitors. Herein we report our discovery of novel SIRT2 inhibitors using a fragment-based approach. Inspired by the purported close binding proximity of suramin and nicotinamide, we prepared two sets of fragments, namely, the naphthylamide sulfonic acids and the naphthalene-benzamides and -nicotinamides. Biochemical evaluation of these two series provided structure-activity relationship (SAR) information, which led to the design of (5-benzamidonaphthalen-1/2-yloxy)nicotinamide derivatives. Among these inhibitors, one compound exhibited high anti-SIRT2 activity (48 nM) and excellent selectivity for SIRT2 over SIRT1 and SIRT3. In vitro, it also increased the acetylation level of a-tubulin, a well-established SIRT2 substrate, in both concentration- and time-dependent manners. Further kinetic studies revealed that this compound behaves as a competitive inhibitor against the peptide substrate and most likely as a noncompetitive inhibitor against NAD(+). Taken together, these results indicate that we have discovered a potent and selective SIRT2 inhibitor whose novel structure merits further exploration.

  DOI：

  10.1021/jm500777s

文献信息

• Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach
  作者：Huaqing Cui、Zeeshan Kamal、Teng Ai、Yanli Xu、Swati S. More、Daniel J. Wilson、Liqiang Chen

  DOI：10.1021/jm500777s

  日期：2014.10.23

  Sirtuin 2 (SIRT2) is one of the sirtuins, a family of NAD(+)-dependent deacetylases that act on a variety of histone and non-histone substrates. Accumulating biological functions and potential therapeutic applications have drawn interest in the discovery and development of SIRT2 inhibitors. Herein we report our discovery of novel SIRT2 inhibitors using a fragment-based approach. Inspired by the purported close binding proximity of suramin and nicotinamide, we prepared two sets of fragments, namely, the naphthylamide sulfonic acids and the naphthalene-benzamides and -nicotinamides. Biochemical evaluation of these two series provided structure-activity relationship (SAR) information, which led to the design of (5-benzamidonaphthalen-1/2-yloxy)nicotinamide derivatives. Among these inhibitors, one compound exhibited high anti-SIRT2 activity (48 nM) and excellent selectivity for SIRT2 over SIRT1 and SIRT3. In vitro, it also increased the acetylation level of a-tubulin, a well-established SIRT2 substrate, in both concentration- and time-dependent manners. Further kinetic studies revealed that this compound behaves as a competitive inhibitor against the peptide substrate and most likely as a noncompetitive inhibitor against NAD(+). Taken together, these results indicate that we have discovered a potent and selective SIRT2 inhibitor whose novel structure merits further exploration.
• Novel Naphthalene Derivatives as Inhibitors of Human Immunoglobulin E Antibody Production
  作者：Masaichi Hasegawa、Kazuya Takenouchi、Katsushi Takahashi、Takahiro Takeuchi、Keiji Komoriya、Yasuhide Uejima、Takashi Kamimura

  DOI：10.1021/jm9605041

  日期：1997.2.1

  potency. Similarly, inhibitory activities were lost when the CO2H moiety at the 2-position was moved to the 3- or 4-position on the terminal benzene. These observations suggest that the conformation around the anthranilic acid moiety affects the inhibitory activities toward IgE biosynthesis. 2-(4-(2-Naphthyloxy)benzamido)benzoic acid (29) seemed to be a more potent inhibitor of IgE production than of IgG

  制备了一系列在2位带有多个取代基的萘衍生物，以评估其对由抗CD40抗体（α-CD40）激发的人外周血单核细胞对免疫球蛋白E（IgE）抗体产生的抑制作用，白介素4（IL-4）和白介素10（IL-10）。在2萘基核和邻氨基苯甲酸之间具有1,4-亚苯基间隔区的化合物优先于IgG抗体在体外抑制IgE抗体的产生，而不会影响细胞生存力。邻氨基苯甲酸部分的缺失减少了抑制活性。将2-萘基变为1-萘基或苯基核不会导致效力改变，表明该位置的芳族基团对于抑制活性是必不可少的。另一方面，更改1 将4-亚苯基间隔基与1，3-亚苯基间隔基导致效力降低。类似地，当2位的CO2H部分移至末端苯的3位或4位时，抑制活性丧失。这些观察结果表明，邻氨基苯甲酸部分周围的构象影响了对IgE生物合成的抑制活性。2-（4-（2-萘氧基）苯甲酰胺基）苯甲酸（29）似乎是IgE产生比IgG产生更有效的抑制剂。亚甲基在亚苯基间和酰胺部分之​